| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/23/2011 | EP2297102A1 Heteroaromatic monoamides as orexinin receptor antagonists |
| 03/23/2011 | EP2019837B1 Compounds and compositions as channel activating protease inhibitors |
| 03/23/2011 | EP1463529B9 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/23/2011 | CN101990544A Synthetic peptides used for treating the skin and use thereof in cosmetic or dermopharmaceutical compositions |
| 03/22/2011 | US7910770 3-Isopropoxy-7-methoxy-N-(1H-1,2,3,4-tetrazol-5-yl)-1-benzo[b]thiophene-2-carboxamide; autoimmune diseases such as rheumatoid arthritis, immune thrombocytopenia purpura, systemic lupus erythematosus and Crohn's disease |
| 03/22/2011 | US7910691 Tumor antigen specific immunoglobulin for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 03/22/2011 | US7910556 PAR-2 agonist |
| 03/22/2011 | US7910553 Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux |
| 03/22/2011 | US7910543 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 03/22/2011 | CA2427072C N-alkylglycine trimers capable of protecting neurons against excitotoxic aggressions and compositions containing said trimers |
| 03/22/2011 | CA2407592C Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
| 03/17/2011 | US20110065799 Urokinase inhibitors, production and use thereof |
| 03/17/2011 | US20110065648 Advantageous mu-opiate receptor peptide compounds |
| 03/17/2011 | US20110065179 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
| 03/17/2011 | US20110064741 Stable amyloid beta monomers and oligomers |
| 03/17/2011 | CA2773737A1 Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295401A2 Deuterated hepatitis C protease inhibitors |
| 03/16/2011 | EP2295064A1 Monoclonal antibody therapy for pancreas cancer |
| 03/16/2011 | EP2293847A1 Depsipeptides and their therapeutic use |
| 03/16/2011 | EP2293846A1 Depsipeptides and their therapeutic use |
| 03/16/2011 | EP2293845A1 Depsipeptides and their therapeutic use |
| 03/16/2011 | EP1943267B1 A process for the preparation of perindopril erbumine |
| 03/16/2011 | EP1420010B1 Amphoteric lipid compound and use thereof |
| 03/16/2011 | CN101985463A Method for separating and preparing lysinopril by using membrane separation technology |
| 03/16/2011 | CN101985462A Method for separating lisinopril ester |
| 03/16/2011 | CN101985437A Naphtha uracil peptide nucleic acid (PNA) monomer, intermediate thereof as well as preparation methods and applications thereof |
| 03/15/2011 | US7906550 Viricide against hepatitis virus; pyrrole derivatives as, for example, 3-acetyl-4,5-dimethyl-2-pyrrole carboxylic acid |
| 03/15/2011 | US7906484 Complex for transferring an anionic substance into a cell |
| 03/15/2011 | CA2396030C Camptothecin .beta.-alanine esters with topoisomerase i inhibition |
| 03/10/2011 | WO2011027897A1 Method for manufacturing a lipidic peptide compound |
| 03/10/2011 | WO2011027290A1 Antibiotic compounds |
| 03/10/2011 | WO2011027048A1 Transglutaminase-activating peptide, and cosmetic or pharmaceutical composition containing same |
| 03/10/2011 | US20110059897 Methods for treating a skin wound |
| 03/10/2011 | US20110059893 Compounds for the treatment of proliferative disorders |
| 03/10/2011 | US20110059091 Inhibitors of oncogenic isoforms and uses thereof |
| 03/10/2011 | US20110059047 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 03/10/2011 | CA2772742A1 Antibiotic compounds |
| 03/09/2011 | EP2292750A2 Alanine 2, 3 aminomutases |
| 03/09/2011 | EP2292749A2 Alanine 2, 3 aminomutases |
| 03/09/2011 | EP2292655A1 Peptides and related molecules that bind to tall-1 |
| 03/09/2011 | EP2292640A2 Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof |
| 03/09/2011 | EP2292639A1 Tubulisine derivatives as anticancer drugs |
| 03/09/2011 | EP2292638A2 MAGE-C2 antigenic peptides and uses thereof |
| 03/09/2011 | EP2291390A1 New optically pure compounds for improved therapeutic efficiency |
| 03/09/2011 | EP2078033B1 Isotopically labeled trapping agent and method for identifying reactive metabolites |
| 03/09/2011 | EP1355910B1 Formulation of boronic acid compounds |
| 03/09/2011 | CN101228180B Tripeptides as hepatitis C virus inhibitors |
| 03/08/2011 | US7902488 Microwave-assisted peptide synthesis |
| 03/08/2011 | US7902333 activated ester of the carboxyl-containing compound (carboxylic acid) is reacted with H217O or H218O in the presence of an activator; labelled amino acid |
| 03/08/2011 | US7902329 Oligopeptide tyrosinase inhibitors and uses thereof |
| 03/08/2011 | US7902327 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 03/08/2011 | US7902144 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 03/08/2011 | US7901894 Kinase inhibitors |
| 03/03/2011 | WO2011024175A1 Macrocyclic compounds, compositions comprising them and methods for preventing or treating hiv infection |
| 03/03/2011 | WO2011024079A2 New peptoid agonists of nerve growth factor receptor and their use as medicaments |
| 03/03/2011 | US20110053840 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides |
| 03/03/2011 | US20110053837 Mineral-peptide chelates |
| 03/03/2011 | US20110053829 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
| 03/03/2011 | US20110053182 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/03/2011 | US20110052587 Peptide or protein comprising a c'-d loop of the cd28 receptor family |
| 03/03/2011 | US20110052519 Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails |
| 03/03/2011 | CA2770338A1 Processes for preparing protease inhibitors of hepatitis c virus |
| 03/02/2011 | EP2290055A2 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic and therapeutic applications |
| 03/02/2011 | EP2289886A1 Peptoid agonists of nerve growth factor and their use as medicaments |
| 03/02/2011 | EP2289564A2 Derivatives of aniline as precursors for F18-labeling |
| 03/02/2011 | EP2288615A1 Selective caspase inhibitors and uses thereof |
| 03/02/2011 | EP1673633B9 Method for detecting feline immunodeficiency virus |
| 03/02/2011 | EP1673385B1 Macrocyclic peptides active against the hepatitis c virus |
| 03/02/2011 | EP1639004B1 Fluorescein-labelled peptides |
| 03/02/2011 | EP1351992B1 Hybrid peptides for treatment of bacteremia and septicemia |
| 03/02/2011 | EP1100824B1 Compounds with growth hormone releasing properties |
| 03/02/2011 | CN101982546A Process for producing dipeptide |
| 03/02/2011 | CN101982458A 3-amino-3-arylpropionic acid and preparation method thereof |
| 03/01/2011 | US7897142 Cyclic nonapeptides coupled to a cyanine dye as an imaging contrast agent; monitoring angiogenesis inhibition |
| 02/24/2011 | US20110046347 Dendritic oligopeptide-grafteded cyclotriphosphazene, a process for the preparation thereof and a drug delivery system containing the same |
| 02/24/2011 | US20110046066 Inhibitors of iap |
| 02/24/2011 | US20110045572 Protein variants having modified immunogenicity |
| 02/24/2011 | US20110045017 Hiv vaccine for mucosal delivery |
| 02/23/2011 | EP2286843A2 Compounds for targeting endothelial cells |
| 02/23/2011 | EP2285822A1 A method for preparing macrocycles |
| 02/23/2011 | CN101981049A 稳定化的液体酶组合物 Stabilized liquid enzyme composition |
| 02/23/2011 | CN101979403A Novel broad caspase inhibitor and preparation method and application thereof |
| 02/23/2011 | CN101979402A Marine cyclic peptide compound and preparation method and use thereof |
| 02/22/2011 | USRE42164 Hepatitis C inhibitor tri-peptides |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893020 can be coadministered with antimicrobial agents for treatment of infections caused by drug resistant bacteria; 2-Amino-N-{4-Amino-1-[-3-phenyl-1-(R)-(quinolin-3-ylcarbomoyl)-propylcarbamoyl]-butyl}succinamic acid; 2,5-Diamino-pentanoic acid [3-phenyl-1-(R)-(4-phenyl-thiazol-2-ylcarbamoyl)-propyl]-amide |
| 02/22/2011 | CA2540678C Pharmaceutical compositions for prevention of overdose or abuse |
| 02/22/2011 | CA2137221C Preparation of 3,4,4-trisubstituted piperidinyl-n-alkylcarboxylates and intermediates |
| 02/17/2011 | WO2011019839A2 Glycopeptide and lipoglycopeptide antibiotics with improved solubility |
| 02/17/2011 | WO2011018467A1 Sultone compound derivatives substituted by nucleophiles, in particular radionuclides, and use thereof for marking macromolecules |
| 02/17/2011 | WO2010138889A8 Peptides for the treatment of hcv infections |
| 02/17/2011 | US20110040087 Peptide turn mimetics |
| 02/17/2011 | US20110040072 Mono and di-substituted oxycodone compounds and compositions |
| 02/17/2011 | US20110039792 Selective Targeting Agents for Mitochondria |
| 02/17/2011 | US20110039786 Metastin derivative and use thereof |
| 02/17/2011 | US20110039752 Stabilized Liquid Enzyme Compositions |
| 02/17/2011 | US20110039714 Probes, Systems, and Methods for Drug Discovery |
| 02/17/2011 | US20110039324 Compositions and methods for enhancing apoptosis |
| 02/17/2011 | US20110038894 Immunogenic Peptides of Tumor Associated Antigen L6 and Uses Thereof in Cancer Therapy |